文献速递乳腺癌

乳腺X线摄影假阳性结果后的乳腺癌发病率

Breast Cancer Incidence After a False-Positive Mammography Result.
PubMed 文献 · JAMA Oncol · 2024-01-01

这项在瑞典开展的基于人群的匹配队列研究纳入45213例首次乳腺X线摄影假阳性女性及452130例匹配对照,发现假阳性者20年乳腺癌累积发病率为11.3% vs 对照7.3%(校正HR 1.61,95%CI 1.54-1.68),乳腺癌死亡风险也更高(HR 1.84,95%CI 1.57-2.15)。作者认为假阳性后的乳腺癌风险因个体特征和随访时间而异,可用于制定个体化风险筛查。

要点

  • 假阳性者20年乳腺癌累积发病率为11.3%,对照为7.3%,校正HR 1.61(95%CI 1.54-1.68)。
  • 假阳性后乳腺癌死亡风险较无假阳性者高84%(HR 1.84,95%CI 1.57-2.15)。
  • 假阳性后癌症更多见于假阳性同侧(HR 1.92,95%CI 1.81-2.04),且随访前4年更常见。

核心结论

  • 本研究提示乳腺X线摄影假阳性结果后发生乳腺癌的风险因个体特征和随访时间而异。
  • 这些发现可用于制定假阳性结果后的个体化风险导向乳腺癌筛查。

研究设计与样本

  • 基于人群的匹配队列研究,1991年1月1日至2020年3月31日在瑞典开展。
  • 纳入1991至2017年间首次乳腺X线摄影假阳性结果的45213例女性,及按年龄、乳腺X线摄影日历年、筛查史匹配的452130例对照。
  • 另纳入1113例假阳性女性及11130例匹配对照,其乳腺X线摄影乳腺密度信息来自Karolinska Mammography Project for Risk Prediction of Breast Cancer研究。
  • 统计分析于2022年4月至2023年2月进行。

主要发现

  • 研究队列共497343例女性(中位年龄52岁,IQR 42-59岁)。
  • 假阳性者20年乳腺癌累积发病率为11.3%(95%CI 10.7%-11.9%),无假阳性者为7.3%(95%CI 7.2%-7.5%),校正HR为1.61(95%CI 1.54-1.68)。
  • 检查时年龄60至75岁女性HR为2.02(95%CI 1.80-2.26),乳腺X线摄影乳腺密度较低者HR为4.65(95%CI 2.61-8.29)。
  • 召回时接受活检者HR为1.77(95%CI 1.63-1.92),未接受活检者HR为1.51(95%CI 1.43-1.60)。
  • 假阳性后癌症更常见于假阳性同侧(HR 1.92,95%CI 1.81-2.04),随访前2年HR为2.57(95%CI 2.33-2.85),>2至4年HR为1.93(95%CI 1.76-2.12)。

关键数值与推荐

  • 假阳性者20年乳腺癌累积发病率为11.3%(95%CI 10.7%-11.9%),对照为7.3%(95%CI 7.2%-7.5%)。
  • 假阳性与乳腺癌发生的校正HR为1.61(95%CI 1.54-1.68)。
  • 检查时年龄60至75岁者HR为2.02(95%CI 1.80-2.26)。
  • 乳腺X线摄影乳腺密度较低者HR为4.65(95%CI 2.61-8.29)。
  • 假阳性者乳腺癌死亡HR为1.84(95%CI 1.57-2.15)。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为这些发现可用于制定假阳性结果后的个体化风险导向乳腺癌筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: False-positive mammography results are common. However, long-term outcomes after a false-positive result remain unclear. OBJECTIVES: To examine long-term outcomes after a false-positive mammography result and to investigate whether the association of a false-positive mammography result with cancer differs by baseline characteristics, tumor characteristics, and time since the false-positive result. DESIGN, SETTING, AND PARTICIPANTS: This population-based, matched cohort study was conducted in Sweden from January 1, 1991, to March 31, 2020. It included 45 213 women who received a first false-positive mammography result between 1991 and 2017 and 452 130 controls matched on age, calendar year of mammography, and screening history (no previous false-positive result). The study also included 1113 women with a false-positive result and 11 130 matched controls with information on mammographic breast density from the Karolinska Mammography Project for Risk Prediction of Breast Cancer study. Statistical analysis was performed from April 2022 to February 2023. EXPOSURE: A false-positive mammography result. MAIN OUTCOMES AND MEASURES: Breast cancer incidence and mortality. RESULTS: The study cohort included 497 343 women (median age, 52 years [IQR, 42-59 years]). The 20-year cumulative incidence of breast cancer was 11.3% (95% CI, 10.7%-11.9%) among women with a false-positive result vs 7.3% (95% CI, 7.2%-7.5%) among those without, with an adjusted hazard ratio (HR) of 1.61 (95% CI, 1.54-1.68). The corresponding HRs were higher among women aged 60 to 75 years at the examination (HR, 2.02; 95% CI, 1.80-2.26) and those with lower mammographic breast density (HR, 4.65; 95% CI, 2.61-8.29). In addition, breast cancer risk was higher for women who underwent a biopsy at the recall (HR, 1.77; 95% CI, 1.63-1.92) than for those without a biopsy (HR, 1.51; 95% CI, 1.43-1.60). Cancers after a false-positive result were more likely to be detected on the ipsilateral side of the false-positive result (HR, 1.92; 95% CI, 1.81-2.04) and were more common during the first 4 years of follow-up (HR, 2.57; 95% CI, 2.33-2.85 during the first 2 years; HR, 1.93; 95% CI, 1.76-2.12 at >2 to 4 years). No statistical difference was found for different tumor characteristics (except for larger tumor size). Furthermore, associated with the increased risk of breast cancer, women with a false-positive result had an 84% higher rate of breast cancer death than those without (HR, 1.84; 95% CI, 1.57-2.15). CONCLUSIONS AND RELEVANCE: This study suggests that the risk of developing breast cancer after a false-positive mammography result differs by individual characteristics and follow-up. These findings can be used to develop individualized risk-based breast cancer screening after a false-positive result.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Mao X, He W, Humphreys K, et al. Breast Cancer Incidence After a False-Positive Mammography Result. JAMA Oncol. 2024. PMID: 37917078. doi:10.1001/jamaoncol.2023.4519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。